The global Pediatric Orphan Drug market was valued at US$ 70250 million in 2023 and is anticipated to reach US$ 149880 million by 2030, witnessing a CAGR of 11.6% during the forecast period 2024-2030.

Pediatric Orphan Drug Market

Orphan drug development is crucial for children, who are disproportionately affected by rare diseases.

North American market for Pediatric Orphan Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pediatric Orphan Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Pediatric Orphan Drug include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Orphan Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Orphan Drug.

The Pediatric Orphan Drug market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pediatric Orphan Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pediatric Orphan Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Orphan Drug Market Report

Report Metric	Details
Report Name	Pediatric Orphan Drug Market
Accounted market size in 2023	US$ 70250 million
Forecasted market size in 2030	US$ 149880 million
CAGR	11.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oncology Pulmonary Neurology Hematology Endocrinology Cardio-vascular Metabolic Disorders Others
Segment by Application	0-1 Years 1-3 Years 3-6 Years 6-12 Years ＞ 12 Years
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, AbbVie, Biogen, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Orphan Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Orphan Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pediatric Orphan Drug Market growing?

Ans: The Pediatric Orphan Drug Market witnessing a CAGR of 11.6% during the forecast period 2024-2030.

What is the Pediatric Orphan Drug Market size in 2030?

Ans: The Pediatric Orphan Drug Market size in 2030 will be US$ 149880 million.

Who are the main players in the Pediatric Orphan Drug Market report?

Ans: The main players in the Pediatric Orphan Drug Market are Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, AbbVie, Biogen, Eli Lilly

What are the Application segmentation covered in the Pediatric Orphan Drug Market report?

Ans: The Applications covered in the Pediatric Orphan Drug Market report are 0-1 Years, 1-3 Years, 3-6 Years, 6-12 Years, ＞ 12 Years

What are the Type segmentation covered in the Pediatric Orphan Drug Market report?

Ans: The Types covered in the Pediatric Orphan Drug Market report are Oncology, Pulmonary, Neurology, Hematology, Endocrinology, Cardio-vascular, Metabolic Disorders, Others

1 Pediatric Orphan Drug Market Overview

1.1 Product Definition

1.2 Pediatric Orphan Drug by Type

1.2.1 Global Pediatric Orphan Drug Market Value Comparison by Type (2024-2030)

1.2.2 Oncology

1.2.3 Pulmonary

1.2.4 Neurology

1.2.5 Hematology

1.2.6 Endocrinology

1.2.7 Cardio-vascular

1.2.8 Metabolic Disorders

1.2.9 Others

1.3 Pediatric Orphan Drug by Application

1.3.1 Global Pediatric Orphan Drug Market Value by Application (2024-2030)

1.3.2 0-1 Years

1.3.3 1-3 Years

1.3.4 3-6 Years

1.3.5 6-12 Years

1.3.6 ＞ 12 Years

1.4 Global Pediatric Orphan Drug Market Size Estimates and Forecasts

1.4.1 Global Pediatric Orphan Drug Revenue 2019-2030

1.4.2 Global Pediatric Orphan Drug Sales 2019-2030

1.4.3 Global Pediatric Orphan Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pediatric Orphan Drug Market Competition by Manufacturers

2.1 Global Pediatric Orphan Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pediatric Orphan Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pediatric Orphan Drug Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Pediatric Orphan Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pediatric Orphan Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pediatric Orphan Drug, Product Type & Application

2.7 Global Key Manufacturers of Pediatric Orphan Drug, Date of Enter into This Industry

2.8 Global Pediatric Orphan Drug Market Competitive Situation and Trends

2.8.1 Global Pediatric Orphan Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pediatric Orphan Drug Players Market Share by Revenue

2.8.3 Global Pediatric Orphan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pediatric Orphan Drug Market Scenario by Region

3.1 Global Pediatric Orphan Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pediatric Orphan Drug Sales by Region: 2019-2030

3.2.1 Global Pediatric Orphan Drug Sales by Region: 2019-2024

3.2.2 Global Pediatric Orphan Drug Sales by Region: 2025-2030

3.3 Global Pediatric Orphan Drug Revenue by Region: 2019-2030

3.3.1 Global Pediatric Orphan Drug Revenue by Region: 2019-2024

3.3.2 Global Pediatric Orphan Drug Revenue by Region: 2025-2030

3.4 North America Pediatric Orphan Drug Market Facts & Figures by Country

3.4.1 North America Pediatric Orphan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pediatric Orphan Drug Sales by Country (2019-2030)

3.4.3 North America Pediatric Orphan Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pediatric Orphan Drug Market Facts & Figures by Country

3.5.1 Europe Pediatric Orphan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pediatric Orphan Drug Sales by Country (2019-2030)

3.5.3 Europe Pediatric Orphan Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pediatric Orphan Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Pediatric Orphan Drug Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pediatric Orphan Drug Sales by Region (2019-2030)

3.6.3 Asia Pacific Pediatric Orphan Drug Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pediatric Orphan Drug Market Facts & Figures by Country

3.7.1 Latin America Pediatric Orphan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pediatric Orphan Drug Sales by Country (2019-2030)

3.7.3 Latin America Pediatric Orphan Drug Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pediatric Orphan Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Pediatric Orphan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pediatric Orphan Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pediatric Orphan Drug Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pediatric Orphan Drug Sales by Type (2019-2030)

4.1.1 Global Pediatric Orphan Drug Sales by Type (2019-2024)

4.1.2 Global Pediatric Orphan Drug Sales by Type (2025-2030)

4.1.3 Global Pediatric Orphan Drug Sales Market Share by Type (2019-2030)

4.2 Global Pediatric Orphan Drug Revenue by Type (2019-2030)

4.2.1 Global Pediatric Orphan Drug Revenue by Type (2019-2024)

4.2.2 Global Pediatric Orphan Drug Revenue by Type (2025-2030)

4.2.3 Global Pediatric Orphan Drug Revenue Market Share by Type (2019-2030)

4.3 Global Pediatric Orphan Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pediatric Orphan Drug Sales by Application (2019-2030)

5.1.1 Global Pediatric Orphan Drug Sales by Application (2019-2024)

5.1.2 Global Pediatric Orphan Drug Sales by Application (2025-2030)

5.1.3 Global Pediatric Orphan Drug Sales Market Share by Application (2019-2030)

5.2 Global Pediatric Orphan Drug Revenue by Application (2019-2030)

5.2.1 Global Pediatric Orphan Drug Revenue by Application (2019-2024)

5.2.2 Global Pediatric Orphan Drug Revenue by Application (2025-2030)

5.2.3 Global Pediatric Orphan Drug Revenue Market Share by Application (2019-2030)

5.3 Global Pediatric Orphan Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bristol-Myers Squibb

6.1.1 Bristol-Myers Squibb Company Information

6.1.2 Bristol-Myers Squibb Description and Business Overview

6.1.3 Bristol-Myers Squibb Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bristol-Myers Squibb Pediatric Orphan Drug Product Portfolio

6.1.5 Bristol-Myers Squibb Recent Developments/Updates

6.2 Roche

6.2.1 Roche Company Information

6.2.2 Roche Description and Business Overview

6.2.3 Roche Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Roche Pediatric Orphan Drug Product Portfolio

6.2.5 Roche Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Company Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis Pediatric Orphan Drug Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Johnson & Johnson

6.4.1 Johnson & Johnson Company Information

6.4.2 Johnson & Johnson Description and Business Overview

6.4.3 Johnson & Johnson Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson & Johnson Pediatric Orphan Drug Product Portfolio

6.4.5 Johnson & Johnson Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Company Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer Pediatric Orphan Drug Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Amgen

6.6.1 Amgen Company Information

6.6.2 Amgen Description and Business Overview

6.6.3 Amgen Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Amgen Pediatric Orphan Drug Product Portfolio

6.6.5 Amgen Recent Developments/Updates

6.7 Sanofi

6.7.1 Sanofi Company Information

6.7.2 Sanofi Description and Business Overview

6.7.3 Sanofi Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Sanofi Pediatric Orphan Drug Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 AstraZeneca

6.8.1 AstraZeneca Company Information

6.8.2 AstraZeneca Description and Business Overview

6.8.3 AstraZeneca Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 AstraZeneca Pediatric Orphan Drug Product Portfolio

6.8.5 AstraZeneca Recent Developments/Updates

6.9 Takeda

6.9.1 Takeda Company Information

6.9.2 Takeda Description and Business Overview

6.9.3 Takeda Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Takeda Pediatric Orphan Drug Product Portfolio

6.9.5 Takeda Recent Developments/Updates

6.10 Vertex Pharmaceuticals

6.10.1 Vertex Pharmaceuticals Company Information

6.10.2 Vertex Pharmaceuticals Description and Business Overview

6.10.3 Vertex Pharmaceuticals Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Vertex Pharmaceuticals Pediatric Orphan Drug Product Portfolio

6.10.5 Vertex Pharmaceuticals Recent Developments/Updates

6.11 AbbVie

6.11.1 AbbVie Company Information

6.11.2 AbbVie Description and Business Overview

6.11.3 AbbVie Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 AbbVie Pediatric Orphan Drug Product Portfolio

6.11.5 AbbVie Recent Developments/Updates

6.12 Biogen

6.12.1 Biogen Company Information

6.12.2 Biogen Description and Business Overview

6.12.3 Biogen Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Biogen Pediatric Orphan Drug Product Portfolio

6.12.5 Biogen Recent Developments/Updates

6.13 Eli Lilly

6.13.1 Eli Lilly Company Information

6.13.2 Eli Lilly Description and Business Overview

6.13.3 Eli Lilly Pediatric Orphan Drug Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Eli Lilly Pediatric Orphan Drug Product Portfolio

6.13.5 Eli Lilly Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pediatric Orphan Drug Industry Chain Analysis

7.2 Pediatric Orphan Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pediatric Orphan Drug Production Mode & Process

7.4 Pediatric Orphan Drug Sales and Marketing

7.4.1 Pediatric Orphan Drug Sales Channels

7.4.2 Pediatric Orphan Drug Distributors

7.5 Pediatric Orphan Drug Customers

8 Pediatric Orphan Drug Market Dynamics

8.1 Pediatric Orphan Drug Industry Trends

8.2 Pediatric Orphan Drug Market Drivers

8.3 Pediatric Orphan Drug Market Challenges

8.4 Pediatric Orphan Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vertex Pharmaceuticals

List of Tables

Table 1. Global Pediatric Orphan Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pediatric Orphan Drug Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Pediatric Orphan Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pediatric Orphan Drug Sales (Tons) of Key Manufacturers (2019-2024)

Table 5. Global Pediatric Orphan Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pediatric Orphan Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pediatric Orphan Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pediatric Orphan Drug Average Price (US$/kg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pediatric Orphan Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pediatric Orphan Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pediatric Orphan Drug, Product Type & Application

Table 12. Global Key Manufacturers of Pediatric Orphan Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pediatric Orphan Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pediatric Orphan Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pediatric Orphan Drug Sales by Region (2019-2024) & (Tons)

Table 18. Global Pediatric Orphan Drug Sales Market Share by Region (2019-2024)

Table 19. Global Pediatric Orphan Drug Sales by Region (2025-2030) & (Tons)

Table 20. Global Pediatric Orphan Drug Sales Market Share by Region (2025-2030)

Table 21. Global Pediatric Orphan Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pediatric Orphan Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Pediatric Orphan Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pediatric Orphan Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Pediatric Orphan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)

Table 27. North America Pediatric Orphan Drug Sales by Country (2025-2030) & (Tons)

Table 28. North America Pediatric Orphan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pediatric Orphan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pediatric Orphan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)

Table 32. Europe Pediatric Orphan Drug Sales by Country (2025-2030) & (Tons)

Table 33. Europe Pediatric Orphan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pediatric Orphan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pediatric Orphan Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pediatric Orphan Drug Sales by Region (2019-2024) & (Tons)

Table 37. Asia Pacific Pediatric Orphan Drug Sales by Region (2025-2030) & (Tons)

Table 38. Asia Pacific Pediatric Orphan Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pediatric Orphan Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pediatric Orphan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)

Table 42. Latin America Pediatric Orphan Drug Sales by Country (2025-2030) & (Tons)

Table 43. Latin America Pediatric Orphan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pediatric Orphan Drug Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Pediatric Orphan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)

Table 47. Middle East and Africa Pediatric Orphan Drug Sales by Country (2025-2030) & (Tons)

Table 48. Middle East and Africa Pediatric Orphan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Pediatric Orphan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pediatric Orphan Drug Sales (Tons) by Type (2019-2024)

Table 51. Global Pediatric Orphan Drug Sales (Tons) by Type (2025-2030)

Table 52. Global Pediatric Orphan Drug Sales Market Share by Type (2019-2024)

Table 53. Global Pediatric Orphan Drug Sales Market Share by Type (2025-2030)

Table 54. Global Pediatric Orphan Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pediatric Orphan Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pediatric Orphan Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Pediatric Orphan Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Pediatric Orphan Drug Price (US$/kg) by Type (2019-2024)

Table 59. Global Pediatric Orphan Drug Price (US$/kg) by Type (2025-2030)

Table 60. Global Pediatric Orphan Drug Sales (Tons) by Application (2019-2024)

Table 61. Global Pediatric Orphan Drug Sales (Tons) by Application (2025-2030)

Table 62. Global Pediatric Orphan Drug Sales Market Share by Application (2019-2024)

Table 63. Global Pediatric Orphan Drug Sales Market Share by Application (2025-2030)

Table 64. Global Pediatric Orphan Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pediatric Orphan Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pediatric Orphan Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Pediatric Orphan Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Pediatric Orphan Drug Price (US$/kg) by Application (2019-2024)

Table 69. Global Pediatric Orphan Drug Price (US$/kg) by Application (2025-2030)

Table 70. Bristol-Myers Squibb Company Information

Table 71. Bristol-Myers Squibb Description and Business Overview

Table 72. Bristol-Myers Squibb Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 73. Bristol-Myers Squibb Pediatric Orphan Drug Product

Table 74. Bristol-Myers Squibb Recent Developments/Updates

Table 75. Roche Company Information

Table 76. Roche Description and Business Overview

Table 77. Roche Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 78. Roche Pediatric Orphan Drug Product

Table 79. Roche Recent Developments/Updates

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 83. Novartis Pediatric Orphan Drug Product

Table 84. Novartis Recent Developments/Updates

Table 85. Johnson & Johnson Company Information

Table 86. Johnson & Johnson Description and Business Overview

Table 87. Johnson & Johnson Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 88. Johnson & Johnson Pediatric Orphan Drug Product

Table 89. Johnson & Johnson Recent Developments/Updates

Table 90. Pfizer Company Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 93. Pfizer Pediatric Orphan Drug Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Amgen Company Information

Table 96. Amgen Description and Business Overview

Table 97. Amgen Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 98. Amgen Pediatric Orphan Drug Product

Table 99. Amgen Recent Developments/Updates

Table 100. Sanofi Company Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 103. Sanofi Pediatric Orphan Drug Product

Table 104. Sanofi Recent Developments/Updates

Table 105. AstraZeneca Company Information

Table 106. AstraZeneca Description and Business Overview

Table 107. AstraZeneca Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 108. AstraZeneca Pediatric Orphan Drug Product

Table 109. AstraZeneca Recent Developments/Updates

Table 110. Takeda Company Information

Table 111. Takeda Description and Business Overview

Table 112. Takeda Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 113. Takeda Pediatric Orphan Drug Product

Table 114. Takeda Recent Developments/Updates

Table 115. Vertex Pharmaceuticals Company Information

Table 116. Vertex Pharmaceuticals Description and Business Overview

Table 117. Vertex Pharmaceuticals Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 118. Vertex Pharmaceuticals Pediatric Orphan Drug Product

Table 119. Vertex Pharmaceuticals Recent Developments/Updates

Table 120. AbbVie Company Information

Table 121. AbbVie Description and Business Overview

Table 122. AbbVie Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 123. AbbVie Pediatric Orphan Drug Product

Table 124. AbbVie Recent Developments/Updates

Table 125. Biogen Company Information

Table 126. Biogen Description and Business Overview

Table 127. Biogen Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 128. Biogen Pediatric Orphan Drug Product

Table 129. Biogen Recent Developments/Updates

Table 130. Eli Lilly Company Information

Table 131. Eli Lilly Description and Business Overview

Table 132. Eli Lilly Pediatric Orphan Drug Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 133. Eli Lilly Pediatric Orphan Drug Product

Table 134. Eli Lilly Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Pediatric Orphan Drug Distributors List

Table 138. Pediatric Orphan Drug Customers List

Table 139. Pediatric Orphan Drug Market Trends

Table 140. Pediatric Orphan Drug Market Drivers

Table 141. Pediatric Orphan Drug Market Challenges

Table 142. Pediatric Orphan Drug Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pediatric Orphan Drug

Figure 2. Global Pediatric Orphan Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pediatric Orphan Drug Market Share by Type: 2023 & 2030

Figure 4. Oncology Product Picture

Figure 5. Pulmonary Product Picture

Figure 6. Neurology Product Picture

Figure 7. Hematology Product Picture

Figure 8. Endocrinology Product Picture

Figure 9. Cardio-vascular Product Picture

Figure 10. Metabolic Disorders Product Picture

Figure 11. Others Product Picture

Figure 12. Global Pediatric Orphan Drug Market Value by Application (2024-2030) & (US$ Million)

Figure 13. Global Pediatric Orphan Drug Market Share by Application: 2023 & 2030

Figure 14. 0-1 Years

Figure 15. 1-3 Years

Figure 16. 3-6 Years

Figure 17. 6-12 Years

Figure 18. ＞ 12 Years

Figure 19. Global Pediatric Orphan Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Pediatric Orphan Drug Market Size (2019-2030) & (US$ Million)

Figure 21. Global Pediatric Orphan Drug Sales (2019-2030) & (Tons)

Figure 22. Global Pediatric Orphan Drug Average Price (US$/kg) & (2019-2030)

Figure 23. Pediatric Orphan Drug Report Years Considered

Figure 24. Pediatric Orphan Drug Sales Share by Manufacturers in 2023

Figure 25. Global Pediatric Orphan Drug Revenue Share by Manufacturers in 2023

Figure 26. Global 5 and 10 Largest Pediatric Orphan Drug Players: Market Share by Revenue in Pediatric Orphan Drug in 2023

Figure 27. Pediatric Orphan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 28. Global Pediatric Orphan Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 29. North America Pediatric Orphan Drug Sales Market Share by Country (2019-2030)

Figure 30. North America Pediatric Orphan Drug Revenue Market Share by Country (2019-2030)

Figure 31. United States Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Canada Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Europe Pediatric Orphan Drug Sales Market Share by Country (2019-2030)

Figure 34. Europe Pediatric Orphan Drug Revenue Market Share by Country (2019-2030)

Figure 35. Germany Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. France Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. U.K. Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Italy Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Russia Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Asia Pacific Pediatric Orphan Drug Sales Market Share by Region (2019-2030)

Figure 41. Asia Pacific Pediatric Orphan Drug Revenue Market Share by Region (2019-2030)

Figure 42. China Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Japan Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. South Korea Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. India Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Australia Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. China Taiwan Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Pediatric Orphan Drug Sales Market Share by Country (2019-2030)

Figure 50. Mexico Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Colombia Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East and Africa Pediatric Orphan Drug Sales Market Share by Country (2019-2030)

Figure 55. Middle East and Africa Pediatric Orphan Drug Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. UAE Pediatric Orphan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Pediatric Orphan Drug by Type (2019-2030)

Figure 60. Global Revenue Market Share of Pediatric Orphan Drug by Type (2019-2030)

Figure 61. Global Pediatric Orphan Drug Price (US$/kg) by Type (2019-2030)

Figure 62. Global Sales Market Share of Pediatric Orphan Drug by Application (2019-2030)

Figure 63. Global Revenue Market Share of Pediatric Orphan Drug by Application (2019-2030)

Figure 64. Global Pediatric Orphan Drug Price (US$/kg) by Application (2019-2030)

Figure 65. Pediatric Orphan Drug Value Chain

Figure 66. Pediatric Orphan Drug Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Compound Antibacterial Agent for Animal - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-38V14855

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Antipyretic Stickers Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-22E8302

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions